Conceptual Questions Flashcards
What is the real purchase price?
- dep on exact treatment of sellers cash and debt, transaction fees
- but closest to Purchase EqV
- eg. excess seller cash usuall distributed to shareholders
- eg. buyer usually refinances existing seller debt and replace w debt in same amt so doesn’t pay extra for it
- could end up with Purchase Equity Value + Transaction/Financing Fees
– Seller’s Excess Cash - but variations are possible
Why in the purchase price equation for public cos, debt is not mentioned?
b/c buyer almost always refinances seller’s existing debt and replaces it w new debt in same amt
- so no “paying extra”
What info do you need from both cos to start merger model?
minimum IS projections for next couple of years
What does a sources and uses schedule do?
- purchase price is not exactly equal to either Purchase EqV or Purvhase TEV
- so we need S&U to tells u how much buyer really pays for seller
What is le structure of the Sources & Uses Schedule?
- U side: add up total cost of acquiring co, S side: amt of cash debt stock to pay for everything
Cash free debt free private seller vs standard public m&a- diff when deal closes?
for private
- cash and debt set to 0
- cash replaced to seller min cash
- debt replaced with new issuance to same level
Cash free debt free private seller vs standard public m&a- purchase price multiple?
TEV multiple, not share price premium
Cash free debt free private seller vs standard public m&a- S&U
based on Purchase TEV, target min cash, transaction fees
What is the purpose of a purchase price allocation scedule?
- estimate goodwill
- write ups of assets eg. PPE, intangibles
- creation of DTLs
- changes to existing deferred tax items
Why do Deferred Tax Liabilities get created in many M&A deals?
- in an M&A deal in which buyer purchases all seller’s shares and gets everything seller has
- DTLs created b/c the D&A on asset write ups is not deductible for cash tax purposes in a stock purchases
Why do many merger models overstate impact of synergies?
- many don’t include costs associated w revenue synergies eg. COGS, Opex
- realizing synergies takes time- not just in Y1
How do you calculate the combined co’s debt repayment capacity in merger model?
- create mini cash flow statement
- elimiate most of financing and investing sections except for capex
- keep CFO
How should you treat stock based compensation?
- SBC problematic b/c increases diluted share count and reduces value to existing shareholders
- but difficult to estimate impact since have to project details of SBC
- so easiest to count as cash operating expense, don’t add back on standalone and combined CFS
IRR vs DR way of judging M&A- cons?
- which DR to use? buyer, seller or weighted average?
- where do synergies get credited to? buyer or seller?
- Is terminal value for synergies justified given that they won’t last forever?